External Source

Clinical Trial Results Of New Agent For Myelodysplastic Syndromes And Acute Myeloid Leukemia

2012 4:50
Synopsis
Raoul Tibes, M.D., Ph.D., hematologist and scientist at Mayo Clinic in Arizona, discusses Phase I clinical trial results of a new ...

You Might Also Like

Promising Phase 2 Trial Results For Patients With Myelodysplastic Syndrome and AML 4:33
Promising Phase 2 Trial Results For Patients With Myelodyspl...
2020
Virtual Series Session 3: Myelodysplastic Syndromes and Acute Myeloid Leukemia 1:36:58
Virtual Series Session 3: Myelodysplastic Syndromes And Acut...
2020
Clinical trials of immune checkpoint inhibitors in acute myeloid leukemia (AML) 2:11
Clinical Trials Of Immune Checkpoint Inhibitors In Acute Mye...
2017
Clinical trials aiming to reduce the toxicity of novel agents in AML 6:41
Clinical Trials Aiming To Reduce The Toxicity Of Novel Agent...
2023
Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome 1:32:49
Community Perspectives On Acute Myeloid Leukemia And Higher-...
2022
How can I choose a clinical trial for AML? 3:11
How Can I Choose A Clinical Trial For Aml?
2019
Exploring Promising Treatments and Clinical Trials for #AML Patients #MDS 2:58
Exploring Promising Treatments And Clinical Trials For #aml ...
2024
Targeted agents in acute myeloid leukemia in elderly patients 1:46
Targeted Agents In Acute Myeloid Leukemia In Elderly Patient...
2017
Beat AML: A New Clinical Trial for Acute Myeloid Leukemia Patients 4:43
Beat Aml: A New Clinical Trial For Acute Myeloid Leukemia Pa...
2016
The future of AML and MDS diagnosis and treatment 1:41
The Future Of Aml And Mds Diagnosis And Treatment
2017
TP53-mutated MDS & AML: a key unmet need & the value of enrolling patients in clinical trials 1:09
Tp53-mutated Mds & Aml: A Key Unmet Need & The Value Of Enro...
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.